Total Payments
$5,293
2024 Payments
$1,030
Companies
57
Transactions
251
Medicare Patients
3,514
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$4,824 (91.1%)
Education$469.16 (8.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,824 | 243 | 91.1% |
| Education | $469.16 | 8 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $386.57 | 19 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $367.80 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $366.91 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $342.51 | 21 | $0 (2023) |
| Merck Sharp & Dohme LLC | $287.59 | 10 | $0 (2024) |
| PFIZER INC. | $271.44 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $249.42 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $230.47 | 11 | $0 (2023) |
| ABBVIE INC. | $195.62 | 8 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $169.55 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,030 | 32 | ABBVIE INC. ($195.62) |
| 2023 | $1,172 | 55 | Pharmacyclics LLC, An AbbVie Company ($129.16) |
| 2022 | $1,576 | 92 | Novartis Pharmaceuticals Corporation ($204.73) |
| 2021 | $1,141 | 56 | Janssen Biotech, Inc. ($153.47) |
| 2020 | $91.27 | 3 | Pharmacyclics LLC, An AbbVie Company ($50.01) |
| 2019 | $87.45 | 6 | Pharmacyclics LLC, An AbbVie Company ($50.22) |
| 2018 | $172.87 | 6 | Merck Sharp & Dohme Corporation ($106.48) |
| 2017 | $23.59 | 1 | Celgene Corporation ($23.59) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $45.33 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/06/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 11/06/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 11/06/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Monoclonal Antibody | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $1.65 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Monoclonal Antibody | ||||||
| 09/05/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $67.32 | General |
| Category: Oncology | ||||||
| 08/28/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Oncology | ||||||
| 08/14/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $115.92 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2024 | PFIZER INC. | — | Education | In-kind items and services | $96.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 512 | 1,044 | $256,297 | $118,821 |
| 2022 | 26 | 1,113 | 56,949 | $1.9M | $738,773 |
| 2021 | 38 | 1,493 | 77,077 | $2.3M | $840,719 |
| 2020 | 15 | 396 | 20,659 | $151,452 | $50,746 |
Total Patients
3,514
Total Services
155,729
Medicare Billing
$1.7M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 30 | 84 | $5,376 | $1,032 | 19.2% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2022 | 19 | 5,850 | $12,011 | $849.85 | 7.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 13 | 35 | $3,220 | $790.54 | 24.6% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 16 | 18 | $2,664 | $446.20 | 16.7% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 22 | 430 | $6,920 | $339.59 | 4.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 26 | 528 | $126.72 | $50.61 | 39.9% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2022 | 12 | 20 | $99.80 | $42.16 | 42.2% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 17 | 33 | $38.61 | $26.26 | 68.0% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2021 | 16 | 11,000 | $1.1M | $454,960 | 41.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 287 | 1,091 | $227,157 | $104,576 | 46.0% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2021 | 25 | 185 | $271,920 | $51,913 | 19.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 21 | 2,941 | $109,288 | $48,199 | 44.1% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2021 | 33 | 34,500 | $73,140 | $30,993 | 42.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 69 | 253 | $101,959 | $25,916 | 25.4% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2021 | 14 | 6,805 | $51,378 | $17,755 | 34.6% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2021 | 18 | 80 | $75,520 | $15,282 | 20.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 46 | 90 | $14,850 | $14,490 | 97.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 141 | 211 | $29,409 | $13,010 | 44.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 100 | 100 | $31,974 | $11,935 | 37.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 79 | $12,324 | $6,214 | 50.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 69 | 111 | $20,091 | $5,823 | 29.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 35 | $9,850 | $4,675 | 47.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 29 | $10,323 | $4,551 | 44.1% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2021 | 26 | 74 | $14,652 | $3,747 | 25.6% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 13 | 60 | $9,300 | $3,594 | 38.6% |
About Dr. Srinivasu Chamarthy, MD
Dr. Srinivasu Chamarthy, MD is a Hematology & Oncology healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1912137647.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Srinivasu Chamarthy, MD has received a total of $5,293 in payments from pharmaceutical and medical device companies, with $1,030 received in 2024. These payments were reported across 251 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($4,824).
As a Medicare-enrolled provider, Chamarthy has provided services to 3,514 Medicare beneficiaries, totaling 155,729 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Troy, OH
- Active Since 07/15/2009
- Last Updated 07/20/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1912137647
Products in Payments
- IMBRUVICA (Drug) $482.79
- LIBTAYO (Biological) $419.99
- OPDIVO (Biological) $281.70
- KEYTRUDA (Biological) $239.51
- Rezlidhia (Drug) $169.55
- EPKINLY (Drug) $123.79
- COSELA (Drug) $122.73
- KISQALI (Drug) $118.38
- CABOMETYX (Drug) $115.33
- REBLOZYL (Biological) $113.53
- LUMAKRAS (Drug) $103.41
- Lenvima (Drug) $101.49
- Imbruvica (Drug) $100.23
- ENHERTU (Biological) $93.27
- SANCUSO (Drug) $91.01
- TUKYSA (Drug) $89.81
- Monarch Platform (Device) $81.54
- ZEPZELCA (Drug) $74.55
- Pomalyst (Drug) $71.59
- ERLEADA (Drug) $70.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Troy
Dr. Mitchell Folbe, Md, MD
Hematology & Oncology — Payments: $38,995
Hematology & Oncology $38,995
Dr. Thomas Brown, M.d, M.D
Hematology & Oncology — Payments: $19,045
Hematology & Oncology $19,045
Rajeev Kulkarni, Md, MD
Hematology & Oncology — Payments: $9,840
Hematology & Oncology $9,840
Namrata Patel, Md, MD
Hematology & Oncology — Payments: $7,207
Hematology & Oncology $7,207
Joseph Lavelle, D.o, D.O
Hematology & Oncology — Payments: $383.03
Hematology & Oncology $383.03
Dr. Josephine Dela Cruz, Md, MD
Hematology & Oncology — Payments: $320.31
Hematology & Oncology $320.31